R. Beasley, A. Semprini, and E. A. Mitchell, Risk factors for asthma: is prevention possible?, Lancet, vol.386, pp.1075-85, 2015.

I. D. Pavord, R. Beasley, and A. Agusti, After asthma: redefining airways diseases, Lancet, vol.391, pp.350-400, 2017.

M. L. Fajt and S. E. Wenzel, Asthma phenotypes and the use of biologic medications in asthma and allergic disease: The next steps toward personalized care, J Allergy Clin Immunol, vol.135, pp.299-310, 2015.

S. E. Wenzel, Asthma phenotypes: the evolution from clinical to molecular approaches, Nat Med, vol.18, pp.716-741, 2012.

K. F. Chung and J. A. Marwick, Molecular mechanisms of oxidative stress in airways and lungs with reference to asthma and chronic obstructive pulmonary disease, Ann N Y Acad Sci, vol.1203, pp.85-91, 2010.

M. Mittal, M. R. Siddiqui, and K. Tran, Reactive oxygen species in inflammation and tissue injury

, Antioxid Redox Signal, vol.20, pp.1126-67, 2014.

M. K. Jensen, Y. Wang, and E. B. Rimm, Fluorescent oxidation products and risk of coronary heart disease: A prospective study in women, J Am Heart Assoc, vol.2, pp.1-7, 2013.

T. Wu, N. Rifai, C. Walter, E. B. Willett, and . Rimm, Plasma Fluorescent Oxidation Products: Independent Predictors of Coronary Heart Disease in Men, Am. J. Epidemiol, vol.166, issue.5, pp.544-51, 2007.

C. M. Rebholz, T. Wu, and L. L. Hamm, The association of plasma fluorescent oxidation products and chronic kidney disease: a case-control study, Am J Nephrol, vol.36, pp.297-304, 2012.

, characteristics in adults of the EGEA study, Eur Respir J, vol.50, p.1701193, 2017.

F. Kauffmann, M. H. Dizier, and I. Annesi-maesano, EGEA (Epidemiological study on the Genetics and Environment of Asthma, bronchial hyperresponsiveness and atopy)--descriptive characteristics, Clin Exp Allergy, vol.29, pp.17-21, 1999.
URL : https://hal.archives-ouvertes.fr/hal-00596450

F. Kauffmann and M. H. Dizier, EGEA (Epidemiological study on the Genetics and Environment of
URL : https://hal.archives-ouvertes.fr/hal-00596450

, Asthma, bronchial hyperresponsiveness and atopy)--design issues

, Clin Exp Allergy J Br Soc Allergy Clin Immunol, vol.25, issue.2, pp.19-22, 1995.

. Pocket, . Management, and . Prevention, A Pocket Guide for Physicians and Nurses Updated 2015 (for Adults and Children Older than 5 Years) BASED ON THE GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION. www.ginasthma.org, 2018.

V. Siroux, A. Boudier, and M. Dolgopoloff, Forced midexpiratory flow between 25% and 75% of forced vital capacity is associated with long-term persistence of asthma and poor asthma outcomes, J Allergy Clin Immunol, vol.137, pp.1709-1716, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01885681

T. Wu, W. C. Willett, and N. Rifai, Plasma fluorescent oxidation products as potential markers of oxidative stress for epidemiologic studies, Am J Epidemiol, vol.166, pp.552-60, 2007.

M. A. Babyak, Rescaling continuous predictors in regression models, Statistical Tips from the Editors of Psychosomatic Medicine, 2009.

F. M. Aldakheel, P. S. Thomas, J. E. Bourke, M. C. Matheson, S. C. Dharmage et al., Relationships between adult asthma and oxidative stress markers and pH in exhaled breath condensate: a systematic review, Allergy, vol.71, issue.6, pp.741-57, 2016.